United Therapeutics
UTHR
#1033
Rank
A$32.95 B
Marketcap
A$768.38
Share price
0.59%
Change (1 day)
12.30%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): A$44.69

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is A$43.41. In 2025 the company made an earnings per share (EPS) of A$43.27 an increase over its 2024 EPS that were of A$37.92.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$44.693.29%
2025A$43.2714.1%
2024A$37.9225.59%
2023A$30.1931.54%
2022A$22.9551.18%
2021A$15.18-9.1%
2020A$16.70-581.4%
2019A-$3.47-117.79%
2018A$19.5042.11%
2017A$13.72-40.93%
2016A$23.2313.45%
2015A$20.47104.29%
2014A$10.02100.29%
2013A$5.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.09-97.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.84-1.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.97-106.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$3.73-108.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
A$10.41-76.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.58-89.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
A-$10.35-123.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.90-97.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel